Back to Browse Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 1

Adipose inflammation: cause or consequence of obesity-related insulin resistance

Authors Ping Jiao, Haiyan Xu

Published 23 October 2008 Volume 2008:1 Pages 25—31

DOI http://dx.doi.org/10.2147/DMSO.S4180

Review by Single-blind

Peer reviewer comments 3

Ping Jiao, Haiyan Xu

Hallett Center for Diabetes and Endocrinology, Brown Medical School, Providence, RI, USA

Abstract: Obesity constitutes a critical risk factor for the development of many life threatening diseases, particularly insulin resistance and type 2 diabetes. Adipose tissue plays an important role in regulating whole body energy homeostatsis and obesity-related insulin resistance. Inflammation has been commonly linked to insulin resistance. Recent studies demonstrated that adipose tissue is an important source for producing inflammatory molecules in the obese state, primarily due to accumulation of macrophages. Animal models deficient in key inflammatory molecules or with reduced adipose macrophage infiltration are protected from development of obesity-related insulin resistance. Repression of adipose inflammation may be a useful approach to ameliorate obesity-associated metabolic disorders.

Keywords: adipose inflammation, insulin resistance, obesity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin

Peng LH, Xu SY, Shan YH, Wei W, Liu S, Zhang CZ, Wu JH, Liang WQ, Gao JQ

International Journal of Nanomedicine 2014, 9:1897-1908

Published Date: 16 April 2014

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A

Vascular Health and Risk Management 2013, 9:593-598

Published Date: 7 October 2013

Fluoroscopic cervical epidural injections in chronic axial or disc-related neck pain without disc herniation, facet joint pain, or radiculitis

Manchikanti L, Cash KA, Pampati V, Malla Y

Journal of Pain Research 2012, 5:227-236

Published Date: 4 July 2012

Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?

Tsolaki F, Gogaki E, Sakkias F, Skatharoudi C, Lopatatzidi C, Tsoulopoulos V, Lampoura S, Topouzis F, Tsolaki M, Kountouras J

Clinical Ophthalmology 2012, 6:45-47

Published Date: 6 January 2012

Giant leiomyoma of the gastroesophageal junction: technique and results of endoscopic full-thickness resection

Bona D, Aiolfi A, Siboni S, Bernardi D, Bonavina L

Clinical and Experimental Gastroenterology 2011, 4:263-267

Published Date: 30 November 2011

Recent achievements in the management of Raynaud’s phenomenon

Magnus Baumhäkel, Michael Böhm

Vascular Health and Risk Management 2010, 6:207-214

Published Date: 30 March 2010

Alogliptin: a new addition to the class of DPP-4 inhibitors

Radha Andukuri, Andjela Drincic, Marc Rendell

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126

Published Date: 21 July 2009

A ‘brain tumor’ in an intravenous drug abuser

Kathir Yoganathan

International Journal of General Medicine 2009, 2:73-75

Published Date: 22 April 2009

Magnetic nanoparticles for gene and drug delivery

Stuart C McBain, Humphrey HP Yiu, Jon Dobson

International Journal of Nanomedicine 2008, 3:169-180

Published Date: 6 June 2008